The Journal of Experimental Medicine
Janeway's Immunobiology 7th Edition
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 20 August 2001. doi:10.1084/jem.194.4.551
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lukacs, N. W.
Right arrow Articles by Cook, D. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lukacs, N. W.
Right arrow Articles by Cook, D. N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0022-1007/2001/8/551/ $5.00
The Journal of Experimental Medicine, Volume 194, Number 4, August 20, 2001 551-556


Brief Definitive Report

Requirement for the Chemokine Receptor CCR6 in Allergic Pulmonary Inflammation

Nicholas W. Lukacsb, Dina M. Prossera, Maria Wiekowskia, Sergio A. Liraa, and Donald N. Cooka
a Department of Immunology, Schering-Plough Research Institute, Kenilworth, NJ 07033
b Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48105

Correspondence to: Donald N. Cook, Pulmonary Division, Duke University Medical Center, Box 2629, Medical Sciences Research Building, Durham, NC 27710. Tel:919-668-5201 Fax:919-668-0494 E-mail:cook0054{at}mc.duke.edu.

Allergic asthmatic responses in the airway are associated with airway hyperreactivity, eosinophil accumulation in the lung, and cytokine production by allergen-specific, T helper cell type 2 (Th2) lymphocytes. Here, we show that in a cockroach antigen (CA) model of allergic pulmonary inflammation, the chemokine macrophage inflammatory protein (MIP)-3{alpha} is expressed in the lung within hours of allergen challenge. To determine the biologic relevance of this expression, mice lacking CCR6, the only known receptor for MIP-3{alpha}, were studied for their response to CA. CCR6-deficient mice were immunized to the same extent as their wild-type counterparts, as judged by cytokine production in antigen-challenged lymphocytes. However, compared with CA-challenged wild-type mice, challenged CCR6-deficient mice had reduced airway resistance, fewer eosinophils around the airway, lower levels of interleukin 5 in the lung, and reduced serum levels of immunoglobulin E. Together, these data demonstrate that MIP-3{alpha} and CCR6 function in allergic pulmonary responses and suggest that these molecules might represent novel therapeutic targets for treatment of asthma.

Key Words: CCR6, MIP-3{alpha}, chemokine, asthma, lung


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS